fda warning peptides bpc-157 tb-500 FDA's Overreach on Compounded Catalog — Research Peptides &
Description
The injection site may feel tender after treatment
How is the response to Vitamin B12 injection therapy monitored
But its also the least safe, least effective, and most demanding type of B12
[DOI] [PubMed] [Google Scholar] Mathieu 2009 Mathieu S, Boutron I, Moher D, Altman DG, Ravaud P
Theoretical and route-specific risks FDA's 2024 review specifically flagged that no published human exposure data exists for the subcutaneous, transdermal, or intranasal routes that compounding pharmacies have offered
